Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 554,220 | 549,360 | 605,510 | 550,530 | 498,770 |
| Marketable Securities | 295,500 | 307,940 | 253,590 | 261,910 | 208,010 |
| Receivables | 1,259,630 | 1,167,090 | 1,118,510 | 1,110,310 | 974,690 |
| Inventories | 1,516,760 | 1,411,200 | 1,398,600 | 1,359,450 | 1,270,610 |
| Other current assets | 56,510 | 64,690 | 131,000 | 129,200 | 84,380 |
| TOTAL | $3,682,620 | $3,500,280 | $3,507,210 | $3,411,400 | $3,036,460 |
| Non-Current Assets | |||||
| Investments And Advances | 129,180 | 132,380 | 125,170 | 127,170 | 136,360 |
| Other Non-Current Assets | 484,880 | 456,780 | 377,900 | 336,830 | 240,200 |
| TOTAL | $614,060 | $589,160 | $503,070 | $464,000 | $376,560 |
| Total Assets | $7,874,590 | $7,508,250 | $7,480,220 | $7,248,360 | $6,649,130 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 264,880 | 287,610 | 197,330 | 208,820 | 225,720 |
| Accrued Expenses | 121,440 | 132,380 | 331,910 | 0 | 0 |
| Other current liabilities | 1,453,760 | 1,229,590 | 1,383,560 | 1,229,920 | 1,197,670 |
| TOTAL | $1,874,570 | $1,706,370 | $1,964,440 | $1,717,290 | $1,691,460 |
| Non-Current Liabilities | |||||
| Long Term Debt | 206,270 | 197,230 | 202,460 | 197,900 | 196,090 |
| aiOther Non-Current Liabilities | 220,170 | 208,480 | 116,450 | 108,690 | 107,060 |
| TOTAL | $777,030 | $741,370 | $678,520 | $674,510 | $603,890 |
| Total Liabilities | $2,651,610 | $2,447,760 | $2,642,970 | $2,391,810 | $2,295,370 |
| Shareholders' Equity | |||||
| Common Shares | 118,620 | 113,230 | 115,250 | 113,230 | 114,140 |
| Retained earnings | 5,005,440 | 4,840,080 | 4,616,140 | 4,629,740 | 4,178,430 |
| Other shareholders' equity | 105,910 | 114,180 | 112,850 | 118,570 | 71,190 |
| TOTAL | $5,222,970 | $5,060,490 | $4,837,240 | $4,856,540 | $4,353,760 |
| Total Liabilities And Equity | $7,874,580 | $7,508,250 | $7,480,210 | $7,248,350 | $6,649,130 |